Press release
Generic Oncology Drugs Market is predicted to rise US$ 41.5 Bn by the end of 2031 at a CAGR 6% | PMR
The generic oncology drugs market is expected to see significant growth in 2022 as more generic versions of cancer treatments become available. Oncology drugs are used to treat cancer, and they can be expensive, making access to generic versions an important way to reduce costs for patients and healthcare systems.There are several types of oncology drugs, including chemotherapy, targeted therapies, and immunotherapies. These drugs work by attacking cancer cells and inhibiting their growth or by boosting the body's immune system to help it fight cancer.
Generic Oncology Drugs Market Revenue for 2020 -US$ 23 Bn
Sales Forecast for Generic Oncology Drugs by 2031 -US$ 41.5 Bn
Global Market Growth (2021-2031) - 6% CAGR
Fastest-Growing Regional Market -South Asia
Request For Free Sample Report of "Generic Oncology Drugs Market"@ https://www.persistencemarketresearch.com/samples/25480
Another factor driving the growth of the generic oncology drugs market is the increasing adoption of generic drugs as a cost-effective alternative to brand-name drugs. Many cancer treatments can be expensive, and the use of generic drugs can help to reduce the overall cost of treatment for patients and healthcare systems.
The generic oncology drugs market is also being fueled by advances in technology and manufacturing processes, which are helping to improve the quality and availability of generic drugs. In addition, regulatory changes and the expiration of patents on some brand-name cancer drugs are also contributing to the growth of this market.
Companies
Novartis AG
Pfizer Inc.
GlaxoSmithKline plc
CELGENE CORPORATION
Teva Pharmaceutical Industries Ltd.
Merck & Company, Inc
Aurobindo Pharma.
Hikma Pharmaceuticals PLC
Mylan N.V.
NATCO Pharma Limited.
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/25480
Several key players in the generic oncology drugs market include Teva Pharmaceuticals, Sandoz, and Mylan. These companies offer a range of generic oncology drugs, including chemotherapy agents, targeted therapies, and immunotherapies.
Overall, the generic oncology drugs market is expected to see strong growth in 2022 and beyond, as increasing demand for cost-effective cancer treatments and advances in technology and manufacturing drive market demand.
Competitive Landscape
Key market participants are focusing on mergers & collaborations to increase their geographical presence. Research & development of novel generic oncology drugs is also a prime area of focus for major market players.
In October 2021, Biocon Ltd., an Indian biopharmaceutical firm, announced the expansion of its generic formulations portfolio in the U.S. Expansion was marked by the launch of Everolimus tablets, which are a generic version of Afinitor. The drug was approved by the FDA in February 2021 and was launched commercially in October.
Ayana, an Israel-based company, got approval for its cancer-killing drug from the FDA. Generic drug Doxorubicin-HCI Liposomal Injection will now be available in the U.S.
In October 2021, with the launch of Abiraterone Acetate, Dr. Reddy's Laboratories became the first Indian pharmaceutical firm to launch an anti-cancer drug in China.
More recent developments related to key generic oncology drug manufacturers have been also been tracked by analysts at Persistence Market Research, which will be accessible in the full report.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/25480
Key Segments Covered in Generic Oncology Drugs Industry Research
By Molecule Type
Large Molecules
Small Molecules
By Route of Administration
Oral Generic Oncology Drugs
Parenteral Generic Oncology Drugs
By Distribution Channel
Generic Oncology Drugs from Hospital Pharmacies
Generic Oncology Drugs from Retail Pharmacies
Generic Oncology Drugs from Online Pharmacies
Generic Oncology Drugs from Managed Care Institutions
For More Premium Insights, Check out the Link:
Wound Healing Assessment Market - https://www.prnewswire.com/news-releases/wound-healing-assessment-market-is-expected-to-reach-us-153-8-mn-by-2031--301469550.html
Liquid Embolic Market - https://www.prnewswire.com/news-releases/liquid-embolic-market-is-projected-to-experience-a-noteworthy-8-9-cagr-to-reach-a-market-valuation-of-approximately-us-580-5-mn-by-2031--301467442.html
North America Vet Compounding Pharmacies Market - https://www.prnewswire.com/news-releases/north-america-vet-compounding-pharmacies-market-is-expected-to-increase-from-us-1-1-bn-in-2020-to-over-us-2-7-bn-by-2031--301467339.html
Car T Cell Therapy Market - https://www.prnewswire.com/news-releases/car-t-cell-therapy-market-is-anticipated-to-reach-us-2-8-bn-by-2031--301436943.html
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Oncology Drugs Market is predicted to rise US$ 41.5 Bn by the end of 2031 at a CAGR 6% | PMR here
News-ID: 2865945 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Oncology
Precision Oncology Market Top Companies Study - Laboratory Corporation of Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies)- Market Outlook And Industry Analysis 2031"
The global Precision Oncology market is estimated to reach over USD…
Veterinary Oncology Market Report 2024 - Veterinary Oncology Market Size, Share …
"The Business Research Company recently released a comprehensive report on the Global Veterinary Oncology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The veterinary oncology market size…
Hepatocellular Carcinoma Pipeline 2024 | Can-Fite BioPharma, Sinocelltech, AVEO …
DelveInsight, "Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatocellular Carcinoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Hepatocellular Carcinoma Pipeline…
Oncology Clinical Trials Market: Collaboration and Innovation in Oncology Resear …
Allied Market Research analysts have recently conducted a comprehensive research study titled "Oncology Clinical Trials Market: Global Outlook and Forecast 2023-2030." The report provides detailed information and analysis on key players in the market, including PAREXEL International, PRA Health Sciences, Syneos Health, Medpace, Novotech, Pivotal, Novartis, Merck, Bristol Myers Squibb company, and F. Hoffmann-La Roche. The study offers an in-depth analysis that encompasses clear market definitions, classifications, manufacturing processes, cost…
Hemato Oncology Testing Market Global Hemato Oncology Testing Market, Hemato Onc …
Global Hemato Oncology Testing Market Research report is an in-depth study of the market Analysis. Along with the most recent patterns and figures that uncovers a wide examination of the market offer. This report provides exhaustive coverage on geographical segmentation, latest demand scope, growth rate analysis with industry revenue and CAGR status. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study…
Oncology Market Size to Hit $447.3 Billion by 2028 | Oncology Industry Forecast …
Market Overview:
According to our experience research team, Oncology Market was valued at USD 283.5 Billion in 2021, and the global Oncology industry is projected to reach a value of USD 447.3 Billion by 2028, at a CAGR of 7.9% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy & Power, Agriculture,…